OXERVATE gtt opht 7 pce

7680670190015 CH-67019 S01XA24 11.99.0.
OXERVATE gtt opht 7 pce
OXERVATE gtt opht 7 pce
1 / 2
google

Details

Product number
6701901
CPT
-
Packaging group
7
Unit
Durchstechflasche(n)
Composition
cenegerminum 0.02 mg, trehalosum dihydricum, mannitolum, dinatrii phosphas et natrii dihydrogenophosphas dihydricus corresp. phosphas 2.66 mg, hypromellosum, macrogolum 6000, methioninum, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile, ad solutionem pro 1 ml.

Articles (1)

Oxervate, collyre
Augentropfen
7
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/08/2024
Patient information leaflet
Français
06/08/2024
Patient information leaflet
Italien
06/08/2024
Professional SmPC
Allemand
07/06/2024
Professional SmPC
Français
07/06/2024
Professional SmPC
Italien
07/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.02 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.66 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Dompé International SA

1860 Aigle

Authorization information

Swissmedic authorization number
67019
Drug name
Oxervate, collyre
Galenic form
AUL
ATC Code
S01XA24
Authorization status
Z
Dispensation category
B
First authorization
06/09/2018
Authorization expiration date
31/12/9999
IT number
11.99.0.
Domain
Human medicine
Field of application
neurotrophe Keratitis bei Erwachsenen

Packaging details

Description (FR)
OXERVATE gtt opht 7 pce
Description (DE)
OXERVATE Gtt Opht 7 Stk
Market launch
06/09/2018
Narcotic (BTM)
No